Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Sanofi crawled time : 14:30 save search
AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids
Published: 2024-04-12 (Crawled : 14:30) - biospace.com/
PRGO | $30.49 1.84% 350K
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: -2.94%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: 0.0%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: -1.06%
H: 0.21%
C: -1.05%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: 0.0%
drug label astrazeneca expansion for kids
Odyssey Therapeutics Appoints Julie Clauss as Chief Operating Officer and Christopher Butler as SVP, Head of Chemistry
Published: 2024-04-02 (Crawled : 14:30) - biospace.com/
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -1.14%
H: 0.02%
C: -1.06%
therapeutics
Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nod for DMD, Hypertension
Published: 2024-03-22 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
PRGO | $30.49 1.84% 350K
|
Health Technology
|
| O: 0.35%
H: 0.99%
C: -1.17%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: -0.43%
H: 0.41%
C: -0.85%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 1.47%
H: 0.23%
C: -0.19%
fda hypertension
Biopharma Layoff Tracker 2024: Catalent, NextCure, Bayer and More Cut Staff
Published: 2024-03-22 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
RLYB | $1.72 2.99% 210K
|
|
| O: 2.44%
H: 0.0%
C: -4.76%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
VXRT | $0.7789 -7.53% 990K
|
Health Technology
|
| O: 1.63%
H: 2.4%
C: 0.8%
TXMD | $1.91 1.06% 8.4K
|
Health Technology
|
| O: 2.61%
H: 1.42%
C: -2.97%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 1.47%
H: 0.23%
C: -0.19%
PTCT | $25.02 1.34% 410K
|
Health Technology
|
| O: 0.1%
H: 0.86%
C: -3.68%
NKTR | $1.285 -2.65% 630K
|
Health Technology
|
| O: 0.3%
H: 2.21%
C: 1.5%
MOR | $17.96 -0.5% 72K
|
Health Technology
|
| O: 0.94%
H: 0.11%
C: -0.11%
GLPG | $28.905 -0.02% 44K
|
Health Technology
|
| O: -0.69%
H: 0.15%
C: -1.3%
AMRN | $0.8761 0.49% 360K
|
Health Technology
|
| O: 0.2%
H: 4.26%
C: -0.41%
GOOGL | News S | $154.29 -1.1% 16M
|
Technology Services
|
| O: 1.03%
H: 1.65%
C: 1.11%
GOOG | News S | $155.48 -1.26% 11M
|
Technology Services
|
| O: 1.01%
H: 1.54%
C: 1.02%
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: 0.0%
H: 0.33%
C: 0.33%
biopharma
Biopharma Layoff Tracker 2024: Bayer, Spruce, Takeda and More Cut Staff
Published: 2024-03-21 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
RLYB | $1.72 2.99% 210K
|
|
| O: 1.19%
H: 0.0%
C: -3.53%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
VXRT | $0.7789 -7.53% 990K
|
Health Technology
|
| O: 0.0%
H: 2.42%
C: -0.81%
TXMD | $1.91 1.06% 8.4K
|
Health Technology
|
| O: 0.43%
H: 1.69%
C: -2.54%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
PTCT | $25.02 1.34% 410K
|
Health Technology
|
| O: 1.56%
H: 3.25%
C: 0.67%
NKTR | $1.285 -2.65% 630K
|
Health Technology
|
| O: 1.44%
H: 1.53%
C: -1.72%
MOR | $17.96 -0.5% 72K
|
Health Technology
|
| O: 0.22%
H: 0.17%
C: -0.22%
GLPG | $28.905 -0.02% 44K
|
Health Technology
|
| O: -0.97%
H: 0.62%
C: -0.62%
AMRN | $0.8761 0.49% 360K
|
Health Technology
|
| O: -0.29%
H: 2.85%
C: -3.68%
GOOGL | News S | $154.29 -1.1% 16M
|
Technology Services
|
| O: 0.49%
H: 0.6%
C: -1.25%
GOOG | News S | $155.48 -1.26% 11M
|
Technology Services
|
| O: 0.43%
H: 0.66%
C: -1.05%
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -0.65%
takeda biopharma
Prefilled Syringes Market, Industry Trends and Global Forecasts, 2035 - Surge in Dual Chamber Format Adoption Amid Growing Player Base
Published: 2024-03-15 (Crawled : 14:30) - prnewswire.com
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
global trends growing
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published: 2024-03-15 (Crawled : 14:30) - prnewswire.com
TAK | News | $13.19 0.23% 740K
|
Health Technology
|
| O: 0.21%
H: 0.97%
C: 0.7%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: 0.05%
H: 0.14%
C: -0.93%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
LLY | $727.48 -2.48% 2M
|
Health Technology
|
| O: -0.7%
H: 0.73%
C: -0.16%
ABBV | News | $166.43 1.08% 2M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
REGN | $894.71 0.08% 180K
|
Health Technology
|
| O: -0.27%
H: 1.26%
C: 0.84%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: 0.2%
H: 1.14%
C: -1.18%
antibody therapeutics market
D3 Bio Appoints Dr. Antoine Yver as Independent Board Member
Published: 2024-03-14 (Crawled : 14:30) - prnewswire.com
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
Vaccine research market size to grow at a CAGR of 9.88% from 2022 to 2027, Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players, Technavio
Published: 2024-03-11 (Crawled : 14:30) - prnewswire.com
CMXHF | $172.54 50
|
n/a
|
| O: 0.41%
H: 0.0%
C: 0.0%
CSLLY | $86.918 60K
|
n/a
|
| O: -4.92%
H: 3.76%
C: 3.44%
GLAXF | $20.2 510
|
Health Technology
|
| O: -3.4%
H: 1.49%
C: 1.49%
AZNCF | $138.24 800
|
Health Technology
|
| O: 1.55%
H: 0.82%
C: 0.16%
ALPMY | $9.47 520K
|
Manufacturing
|
| O: -1.41%
H: 5.06%
C: 4.01%
GSK | $39.585 0.8% 1.1M
|
Health Technology
|
| O: -0.6%
H: 0.19%
C: 0.09%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
AZN | $68.3 -0.09% 2M
|
Health Technology
|
| O: 1.08%
H: 0.82%
C: 0.67%
pharma vaccine astrazeneca research key market
FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug Rejected
Published: 2024-03-11 (Crawled : 14:30) - biospace.com/
PRGO | $30.49 1.84% 350K
|
Health Technology
|
| O: 0.0%
H: 2.38%
C: 1.12%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
fda drug wegovy approved
Decision Tracker: FDA Decisions: Amgen’s Bone-Preserving Blockbuster Picks Up Two New Challengers
Published: 2024-03-06 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.0%
H: 0.8%
C: 0.8%
PRGO | $30.49 1.84% 350K
|
Health Technology
|
| O: -0.15%
H: 3.43%
C: 3.2%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: 0.0%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
fda
FDA Decisions: J&J’s Rybrevant Becomes First Front-Line Treatment for Type of NSCLC
Published: 2024-03-04 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
PRGO | $30.49 1.84% 350K
|
Health Technology
|
| O: 0.65%
H: 1.13%
C: -1.02%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.8%
H: 0.0%
C: 0.0%
fda first treatment rybrevant
PhRMA Names Gilead CEO O’Day as New Board Chair Following Loss of Members
Published: 2024-02-22 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.26%
H: 1.36%
C: 1.36%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: 0.0%
ceo
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Period Activity
Published: 2024-02-15 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.16%
H: 1.48%
C: 0.89%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 1.86%
H: 0.0%
C: 0.0%
ALNY | News | $145.89 0.5% 170K
|
Health Technology
|
| O: -8.62%
H: 2.18%
C: -1.71%
year pharmaceuticals financial results
Sanofi Hit with $600M Net Loss in Q4 Amid Generic Competition
Published: 2024-02-01 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -4.37%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
sanofi
FDA Decisions: Sanofi/Regeneron's Dupixent Racks Up Another Pediatric Indication
Published: 2024-01-26 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.8%
H: 0.0%
C: -1.82%
PRGO | $30.49 1.84% 350K
|
Health Technology
|
| O: 0.72%
H: 0.45%
C: 0.24%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
fda dupixent
FDA Decisions: Theratechnologies Must Address Several Questions in CRL for Lipodystrophy Drug
Published: 2024-01-25 (Crawled : 14:30) - biospace.com/
PRGO | $30.49 1.84% 350K
|
Health Technology
|
| O: 0.73%
H: 0.3%
C: -0.39%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: 0.47%
H: 1.04%
C: 0.93%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -1.27%
H: 0.0%
C: 0.0%
fda drug lipodystrophy
FDA Decisions: J&J's Bladder Cancer Drug Wins Full Approval
Published: 2024-01-22 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.71%
H: 0.0%
C: -0.15%
PRGO | $30.49 1.84% 350K
|
Health Technology
|
| O: 0.36%
H: 2.11%
C: 1.29%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: 0.88%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
fda drug approval bladder cancer
FDA Decisions: CMC Issues Trip Up Satsuma in Nasal Migraine Drug Bid
Published: 2024-01-19 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: -0.83%
PRGO | $30.49 1.84% 350K
|
Health Technology
|
| O: 0.09%
H: 1.01%
C: 0.85%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -1.23%
H: 0.0%
C: 0.0%
fda drug migraine
FDA Decisions: Amgen, Zealand Hit with CRLs in NSCLC, Congenital Hyperinsulinism
Published: 2024-01-03 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.49%
H: 0.0%
C: -0.26%
PRGO | $30.49 1.84% 350K
|
Health Technology
|
| O: 1.9%
H: 0.0%
C: -1.39%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.42%
H: 0.5%
C: 0.21%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: 0.26%
H: 0.1%
C: -0.56%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 1.38%
H: 0.0%
C: 0.0%
fda
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.